Jason R. Ruth
Corporate Officer/Principal presso 501 ACQU
Provenienza dei contatti di primo grado di Jason R. Ruth
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US.
22
| Private Company | Investment Managers | 22 |
7
| Private Company | Financial Conglomerates | 7 |
Merck Research Ventures
 Merck Research Ventures Investment ManagersFinance Merck Research Ventures (Merck Research) is a venture capital subsidiary of Merck Research Laboratories Massachusetts LLC founded in 2000. The firm is headquartered in Cambridge, Massachusetts.
3
| Subsidiary | Investment Managers | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Jason R. Ruth tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| EDITAS MEDICINE, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director/Board Member General Counsel | |
| RALLYBIO CORPORATION | Biotechnology | Founder Director/Board Member | |
Kinaset Therapeutics, Inc.
 Kinaset Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kinaset Therapeutics, Inc. engages in the provision of pharmaceutical services. It develops therapeutics for intractable diseases including severe asthma. The company was founded by Robert Clarke, Roger Heerman, and Frazer Morgan and is headquartered in Medfield, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Boston University | College/University | Undergraduate Degree Director/Board Member | |
| VOR BIOPHARMA INC. | Biotechnology | Chairman Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| The Rockefeller University | College/University | Graduate Degree Doctorate Degree | |
The Brigham & Women's Hospital, Inc.
 The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal Chairman | |
| University of Cambridge | College/University | Graduate Degree Doctorate Degree | |
| University of Oxford | College/University | Undergraduate Degree Graduate Degree | |
| Harvard Medical School | College/University | Corporate Officer/Principal Graduate Degree | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Masters Business Admin Masters Business Admin | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| University of Pennsylvania | College/University | Graduate Degree Graduate Degree | |
Rallybio LLC
 Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
| University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Analyst | |
| CENTESSA PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director/Board Member | |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs. | College/University | Doctorate Degree | |
VV Manager LLC
 VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Founder | |
| KINNATE BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member | |
Affini-T Therapeutics, Inc.
 Affini-T Therapeutics, Inc. BiotechnologyHealth Technology Affini-T Therapeutics, Inc. is a biotechnology company based in Watertown, MA. Affini-t is focused on developing potentially curative therapies for solid tumor cancers by unlocking the power of T cells and targeting core oncogenic drivers. The company's differentiated cell therapy platform harnesses state-of-the-art engineering and synthetic biology capabilities to optimize T cell functions and rewrite the rules of the solid tumor microenvironment, enabling the potential for sustained clinical outcomes in patients. The company is targeting Kras and other oncogenic and viral driver mutations to open a new and differentiated target space, thereby minimizing the risk of cancer. The company was founded by Jak Knowles and Arjun Goyal, with Jak Knowles serving as the CEO since incorporation. | Biotechnology | Founder | |
Scorpion Therapeutics, Inc.
 Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Scorpion Therapeutics, Inc. provides health care services. The company is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
Quanta Therapeutics, Inc.
 Quanta Therapeutics, Inc. BiotechnologyHealth Technology Quanta Therapeutics, Inc. develops biotechnologies. The American company was founded in 2018 by Cameron Pitt, Frank McCormick. Perry D. Nisen has been the CEO of the company since 2021. | Biotechnology | Director/Board Member | |
Alterome Therapeutics, Inc.
 Alterome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alterome Therapeutics, Inc. is a precision oncology biotech that develops alteration-specific therapeutics to address high-value and validated oncogenic drivers. The company is based in San Marcos, CA. The company is led by seasoned R&D leaders with a history of developing marketed oncology small molecule drugs. The company's mission is to discover precise therapies and inspire hope for individuals affected by cancer. The CEO of the company is Eric A. Murphy. | Pharmaceuticals: Major | Director/Board Member | |
Pionyr Immunotherapeutics, Inc.
 Pionyr Immunotherapeutics, Inc. BiotechnologyHealth Technology Pionyr Immunotherapeutics, Inc. develops cancer immunotherapies. It targets the tumor microenvironment to enhance the body?s antitumor immunity. The company was founded by Max Krummel and Sachdev Sidhu in 2015 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
Asklepios BioPharmaceutical, Inc.
 Asklepios BioPharmaceutical, Inc. BiotechnologyHealth Technology Asklepios BioPharmaceutical, Inc. operates as a gene therapy-based company. It engages in capsid development, scaled manufacturing, and a portfolio of therapeutic programs. The company was founded by Richard Jude Samulski, Xiao Xiao, and Sheila A. Mikhail in 2001 and is headquartered in Durham, NC. | Biotechnology | Director/Board Member | |
| PELOTON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Pear Therapeutics (US), Inc.
 Pear Therapeutics (US), Inc. Packaged SoftwareTechnology Services Pear Therapeutics (US), Inc. develops and provides a platform that combines pharmaceutical preparations with scientifically validated software applications. It offers eFormulation, pharmaceutical-software combination products. The firm combines digital therapies with supplements, medical foods and pharmaceuticals to create more effective treatment solutions. The company was founded in 2013 by Corey M. McCann, Stephen Kennedy Smith and William Greene and is headquartered in Boston. MA. | Packaged Software | Private Equity Investor | |
| Stanford University | College/University | Undergraduate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Mozart Therapeutics, Inc.
 Mozart Therapeutics, Inc. BiotechnologyHealth Technology Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning. | Biotechnology | Director/Board Member | |
Xilio Therapeutics LLC
 Xilio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Part of Xilio Therapeutics, Inc., Xilio Therapeutics LLC develops cancer biopharmaceuticals. The company is based in Waltham, MA. The CEO of the company is René Russo. | Pharmaceuticals: Major | Director/Board Member | |
InduPro, Inc.
 InduPro, Inc. BiotechnologyHealth Technology InduPro, Inc. engages in integrating inherent protein proximity at the cell surface and translates biological insights into transformative therapeutics. The company is based in San Francisco, CA. The company was founded by K. Christopher Garcia. | Biotechnology | Director/Board Member | |
Caraway Therapeutics, Inc.
 Caraway Therapeutics, Inc. BiotechnologyHealth Technology Caraway Therapeutics, Inc. provides heathcare services. The company was founded by Timothy Harris, Wade Harper ,Ivan Dikic ,Tony Hyman and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Tallac Therapeutics, Inc.
 Tallac Therapeutics, Inc. BiotechnologyHealth Technology Tallac Therapeutics, Inc. engages in the development of immunomodulating polynucleotides. The company is headquartered in Burlingame, CA. | Biotechnology | Director/Board Member | |
| University of British Columbia | College/University | Undergraduate Degree | |
| University of Geneva | College/University | Doctorate Degree | |
| Yale College | College/University | Undergraduate Degree | |
| The Wayne State University School of Medicine | College/University | Undergraduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Yale School of Medicine | College/University | Doctorate Degree | |
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Biotechnology | Chairman | |
| OMEGA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| NUCANA PLC | Biotechnology | Director/Board Member | |
| LSP Services Deutschland GmbH | Investment Managers | Private Equity Analyst | |
| The Boston Consulting Group | Consultant / Advisor |
Statistiche
Distribuzione geografica
| Stati Uniti | 40 |
| Regno Unito | 5 |
| Israele | 2 |
| Australia | 2 |
| Canada | 2 |
Settori
| Health Technology | 27 |
| Consumer Services | 17 |
| Finance | 4 |
| Health Services | 2 |
| Commercial Services | 2 |
Posizioni
| Director/Board Member | 74 |
| Corporate Officer/Principal | 31 |
| Undergraduate Degree | 24 |
| Private Equity Investor | 21 |
| Independent Dir/Board Member | 19 |
Contatti più connessi
| Insiders | |
|---|---|
| Martin MacKay | 28 |
| Arjun Goyal | 16 |
| Lou Tartaglia | 15 |
| Matt Patterson | 14 |
| Elliott Levy | 14 |
| Paula Soteropoulos | 13 |
| Rebecca Lucia | 12 |
| Peter Dudek | 11 |
| Daniella Beckman | 10 |
| Jamil M. Beg | 10 |
| Galya Blachman | 9 |
| Hannah Chang | 9 |
| Samantha Singer | 9 |
| Deborah Palestrant | 8 |
| Karin Kleinhans | 8 |
- Borsa valori
- Insiders
- Jason R. Ruth
- Connessioni Società
